Acelagraft is a bi-layered, decellularized, dehydrated human amniotic membrane allograft.
INTENDED USES: Acelagraft provides a protective barrier from the external environment and serves as a cover or barrier for acute and chronic wounds. Acelagraft® is indicated for use as a covering for surgical sites, partial- and full-thickness wounds, acute and chronic wounds, including traumatic wounds, burns, diabetic, venous, arterial, and pressure ulcers, and wounds with exposed tendon, muscle, or bone.
CLAIMED BENEFITS: Acelagraft acts to cover and protect damaged tissue by providing a barrier and preserving the wound environment.
Application of Skin Substitutes (also known as Cellular and/or Tissue Based Products) to certain wounds may help these wounds heal faster than conventional dressings and conservative treatments. Usually skin substitutes are used if conventional treatment has been tried for at least 30 days and the wound has not healed as quickly as expected. Human skin allografts are a type of skin substitute. They are made of skin donated by human donors that have had intact cells removed or treated to avoid immunologic rejection (a process in which the body of the person receiving the skin substitute kills the cells of the skin substitute).
For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care
